Abstract
Placenta growth factor (PlGF) (Maglione et al. 1991, 1992), vascular endothelial growth factor (VEGF) (Ferrara and Henzel 1989; Gospodarowicz et al. 1989; Keck et al. 1989; Levy et al. 1989; Conn et al. 1990), VEGF-B (Olofsson et al. 1996), VEGF-C (Joukov et al. 1996) and Fos-induced growth factor (FIGF) (Orlandini et al. 1996) are members of a family of structurally related growth factors. These factors are all dimeric glycoproteins and share a number of biochemical and functional features (for review, see Bussolino et al. 1997). Intra- and interchain disulphide bonds among eight characteristically spaced cysteine residues are involved in the formation of the dimeric active proteins. PIGF and VEGF can form heterodimeric molecules in cells where both genes are expressed (DiSalvo et al. 1995; Cao et al. 1996a). VEGF, the first member of this family to be isolated, was identified for its ability to stimulate the proliferation of endothelial cells (ECs). VEGF exerts its action through the binding to the two receptors, VEGF receptor-1 (VEGFR-1; also denoted Flt-1) and VEGFR-2 (also denoted Flk-l/KDR), abundantly expressed on the ECs.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Barleon B, Sozzani S, Zhou F, Weich HA, Mantovani A, Marmé D (1996) Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood 87:3336–3343.
Bussolino F, Mantovani A, Persico G (1997) Molecular mechanisms of blood vessel formation. TIBS 22:251–256.
Cao Y, Chen H, Zhou L, Chiang M-K, Anand-Apte B, Weatherbee JA, Wang Y, Fang F, Flanagan JG, Lik-Shing Tsang M (1996a) Heterodimers of placenta growth factor/vascular endothelial growth factor. Endothelial activity, tumor cell expression, and high affinity binding to Flk-l/KDR. J Biol Chem 271:3154–3162.
Cao Y, Linden P, Shima D, Brone F, Folkman J (1996b) In vivo angiogenic activity and hypoxia induction of heterodimers of placenta growth factor/vascular endothelial growth factor. J Clin Invest 98:2507–2511.
Clauss M, Weich HA, Breier G, Knies U, Röckl W, Waltenberger J, Risau W (1996) The vascular endothelial growth factor receptor Flt-1 mediates biological activities. J Biol Chem 271:17629–17634
Conn G, Bayne ML, Soderman DD, Kwok PW, Sullivan KA, Palisi TM, Hope DA, Thomas KA (1990) Amino acid and cDNA sequences of a vascular endothelial cell mitogen that is homologous to platelet-derived growth factor. Proc Natl Acad Sci USA 87:2628–2632.
Davis-Smyth T, Chen H, Park J, Presta LG, Ferrara N (1996) The second immunoglobulin-like domain of the VEGF tyrosine kinase receptor Flt-1 determines ligand binding and may initiate a signal transduction cascade. EMBO J 15:4919–41927.
DiPalma T, Tucci M, Russo G, Maglione D, Lago CT, Romano A, Saccone S, DellaValle G, De Gregorio L, Dragani TA, Viglietto G, Persico MG (1996) The placenta growth factor gene of the mouse. Mammalian Genome 7:6–12.
DiSalvo J, Bayne ML, Conn G, Kwock PW, Trivedi PG, Soderman DD, Palisi TM, Sullivan KA, Thomas KA (1995) Purification and characterization of a naturally occurring vascular endothelial growth factor placenta growth factor. J Biol Chem 270:7717–7723.
Ferrara N, Henzel WJ (1989) Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commu. 161:851–858.
Gospodarowicz D, Abraham JA, Schilling J (1989) Isolation and characterization of a vascular endothelial mitogen produced by pituitary-derived folliculo stellate cells. Proc Natl Acad Sci USA 86:7311–7315.
Hatva E, Bohling T, Jaaskelainen J, Persico MG, Haltia M, Alitalo K (1996) Vascular growth factors and receptors in capillary hemangioblastomas and hemangiopericytomas. Am J Pathol 148:763–775.
Hauser S, Weich HA (1993) A heparin-binding form of placenta growth factor (PlGF-) is expressed in human umbilical vein endothelial cells and placenta. Growth Factors 9:259–268.
Joukov V, Pajusola K, Kaipainen A, Chilov D, Lahtinen I, Kukk E, Saksela O, Kalkkinen N, Alitalo K (1996) A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J 15:290–298.
Keck PJ, Hauser SD, Krivi G, Sanzo K, Warren T, Feder J, Connolly DT (1989) Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 246:1309–1312.
Khaliq A, Li XF, Shams M, Sisi P, Acevedo CA, Whittle MJ, Weich HA, Asmed A (1996) Localization of placenta growth factor (PlGF) in human term placenta. Growth Factors 13:243–250.
Landgren E, Schiller P, Cao Y, Claesson-Welsh L (1998) Placenta growth factor stimulates MAP kinase and mitogenicity but not phospholipase C-γ and migration of endothelial cells expressing Fit 1. Oncogene 15 (in press)
Levy AP, Tamargo R, Brem H, Nathans D (1989) An endothelial cell growth factor from the mouse neuroblastoma cell line NB 41. Growth Factors 2:9–19.
Maglione D, Guerriero V, Viglietto G, Delli-Bovi P, Persico MG (1991) Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc Natl Acad Sci USA 88:9267–9271.
Maglione D, Guerriero V, Viglietto G, Risau W, Delli-Bovi P, Persico MG (1992) PIGF: a gene coding for a novel human vascular permeability related protein. In: Lenfant C, Paoletti R, Albertini A (eds) Growth factors of the vascular and nervous system. Karger, Basel, pp 28–33.
Maglione D, Guerriero V, Viglietto G, Ferraro MG, Aprelikova O, Alitalo K, Del Vecchio S, Lei KJ, Chou JY, Persico MG (1993a) Two alternative mRNAs coding for the angiogenic factor, placenta growth factor (PIGF), are transcribed from a single gene of chromosome 14. Oncogene 8:925–931.
Maglione D, Guerriero V, Rambaldi M, Russo G, Persico MG (1993b) Translation of the placenta growth factor mRNA is severely affected by a small open reading frame localized in the 5’ untranslated region. Growth Factors 8:141–152.
Olofsson B, Pajusola K, von Euler G, Chilov D, Alitalo K, Eriksson U (1996) Genomic organization of the mouse and human genes for vascular endothelial growth factor B (VEGF-B) and characterization of a second splice isoform. J Biol Chem 271:19310–19317.
Orlandini M, Marconcini L, Ferruzzi R, Oliviero S (1996) Identification of a c-fos-induced gene that is related to the platelet-derived growth factor/vascular endothelial growth factor family. Proc Natl Acad Sci USA 93:11675–11680.
Park JE, Chen HH, Winer J, Houck KA, Ferrara N (1994) Placenta Growth Factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR. J Biol Chem 269:25646–25654.
Sawano A, Takahashi T, Yamaguchi S, Aonuma M, Shibuya M (1996) Flt-1 but not KDR/Flk-1 tyrosine kinase is a receptor for placenta growth factor, which is releated to vascular endothelial growth factor. Cell Growth Differ 7:213–221.
Takahashi A, Sasaki H, Kim SJ, Tobisu K, Kakizoe T, Tsukamoto T, Kumamoto Y, Sugimura T, Terada M (1994) Markedly increased amount of messenger RNAs for vascular endothelial growth factor and placenta growth factor in renal cell carcinoma associated with angiogenesis. Cancer Res 54:4233–4237.
Terman BI, Khandke L, Dougher-Vermazan M, Maglione D, Lassam NJ, Gospodarowicz D, Persico MG, Bohlen P, Eisinger M (1994) VEGF receptor subtypes KDR and FLT1 show different sensitivities to heparin and placenta growth factor. Growth Factors 11:187–195.
Viglietto G, Maglione D, Rambaldi M, Cerutti J, Romano A, Trapasso F, Fedele M, Ippolito P, Chiappetta G, Botti G, Fusco A, Persico MG (1995) Upregulation of Vascular Endothelial Growth Factor (VEGF) and downregulation of Placenta Growth Factor (PIGF) associated with malignancy in human thyroid tumors and cell lines. Oncogene 11:1569–1579.
Viglietto G, Romano A, Maglione D, Rambaldi M, Paoletti I, Lago CT, Califano D, Monaco C, Mineo A, Santelli G, Manzo G, Botti G, Chiappetta G, Persico MG (1996) Neovascularization in human germ cell tumors correlates with a marked increase in the expression of the vascular endothelial growth factor but not the placenta growth factor. Oncogene 13:577–587.
Viglietto G, Romano A, Manzo G, Chiappetta G, Paoletti I, Califano D, Galati MG, Mauriello V, Bruni P, Lago CT, Fusco A, Persico MG (1997) Upregulation of the angiogenic factors PIGF, VEGF and their receptors (Flt-1, Flk-1/KDR) by TSH in cultured thyrocytes and in the thyroid gland of thiouracil-fed rats suggest a TSH-dependent paracrine mechanism for goiter hypervascularization. Oncogene 15:2687–2698.
Vuorela P, Hatva E, Lymboussaki A, Kaipainen A, Joukov V, Persico MG, Alitalo K, Halmesmäki E (1997) Expression of vascular endothelial growth factor and placenta growth factor in human placenta. Biol Reprod 56:489–494.
Ziche M, Maglione D, Ribatti D, Morbidelli L, Lago CT, Battisti M, Paoletti I, Barra A, Tucci M, Parise G, Vincenti V, Granger HJ, Viglietto G, Persico MG (1997) Placenta growth factor-1 is chemotactic, mitogenic and angiogenic. Lab Invest 76:517–531.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Persico, M.G., Vincenti, V., DiPalma, T. (1999). Structure, Expression and Receptor-Binding Properties of Placenta Growth Factor (PlGF). In: Claesson-Welsh, L. (eds) Vascular Growth Factors and Angiogenesis. Current Topics in Microbiology and Immunology, vol 237. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-59953-8_2
Download citation
DOI: https://doi.org/10.1007/978-3-642-59953-8_2
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-64195-4
Online ISBN: 978-3-642-59953-8
eBook Packages: Springer Book Archive